Cytokinetics Announces Positive Topline Results From MAPLE-HCM
Provided By GlobeNewswire
Last update: May 13, 2025
Trial Demonstrates Superiority of Aficamten to Standard of Care Beta Blocker in Improving Peak Exercise Capacity in Patients with Obstructive Hypertrophic Cardiomyopathy
Read more at globenewswire.com
